Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
36.27B | 42.19B | 55.39B | 40.66B | 32.49B | 35.45B | Gross Profit |
14.98B | 9.25B | 25.65B | 14.46B | 565.00M | 1.49B | EBIT |
-589.00M | 4.55B | 24.14B | 16.00B | 8.87B | 10.90B | EBITDA |
95.00M | 4.55B | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
12.04B | 9.46B | 11.37B | 6.54B | -3.02B | 7.21B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
16.90B | 18.40B | 149.69B | 88.14B | 92.32B | 108.38B | Total Assets |
107.92B | 98.77B | 621.73B | 577.45B | 499.59B | 469.66B | Total Debt |
1.10B | 7.36B | 78.04B | 63.64B | 49.41B | 59.74B | Net Debt |
-15.80B | -18.40B | -71.66B | -24.50B | -43.31B | -49.14B | Total Liabilities |
26.42B | 26.36B | 540.32B | 503.02B | 428.25B | 389.04B | Stockholders Equity |
80.88B | 71.87B | 59.63B | 52.54B | 54.58B | 59.06B |
Cash Flow | Free Cash Flow | ||||
0.00 | -26.63B | 15.12B | -7.47B | 74.81B | 36.07B | Operating Cash Flow |
0.00 | -25.59B | 18.50B | -4.79B | 77.64B | 41.44B | Investing Cash Flow |
0.00 | -8.10B | -17.94B | -7.66B | -8.70B | 5.16B | Financing Cash Flow |
0.00 | 5.16B | 2.58B | -1.72B | -14.75B | -8.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | ¥32.48B | 6.68 | 2.91% | 32.92% | 39.36% | ||
77 Outperform | ¥38.81B | 2.44 | 1.02% | -23.80% | 29.20% | ||
76 Outperform | €32.19B | 14.22 | 5.79% | 5.71% | -2.26% | 6.91% | |
74 Outperform | ¥49.77B | 7.40 | 6.84% | 6.95% | 21.10% | ||
67 Neutral | ¥39.64B | 12.74 | 7.52% | 5.78% | 26.02% | ||
65 Neutral | ¥32.99B | 13.64 | 6.38% | 11.94% | 117.54% | ||
64 Neutral | $12.87B | 9.81 | 7.76% | 16985.65% | 12.28% | -7.83% |